Global Fruquintinib Market Growth 2026-2032
The global Fruquintinib market size is predicted to grow from US$ 456 million in 2025 to US$ 1375 million in 2032; it is expected to grow at a CAGR of 15.6% from 2026 to 2032.
In 2025, global production of fruquintinib reached approximately 810,000 units.Fruquintinib is an oral small-molecule highly selective vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitor, primarily used for the treatment of various solid tumors, with demonstrated efficacy particularly in metastatic colorectal cancer. It exerts its anti-tumor effects by selectively inhibiting VEGFR-1, VEGFR-2, and VEGFR-3 signaling pathways, thereby blocking angiogenesis and suppressing tumor growth and metastasis. Fruquintinib is characterized by high target selectivity, convenient oral administration, and good tolerability, making it clinically valuable in the treatment of advanced cancers, especially in later-line therapy settings.
Fruquintinib, as a highly selective VEGFR tyrosine kinase inhibitor, holds an important position in the oncology targeted therapy market, particularly demonstrating strong competitiveness in the later-line treatment of metastatic colorectal cancer. With the continuous rise in cancer incidence and the widespread adoption of precision medicine, the demand for anti-angiogenic therapies continues to grow, providing a stable market foundation for this drug. From a competitive landscape perspective, anti-angiogenic monoclonal antibodies such as Bevacizumab and small-molecule multi-target TKIs such as Regorafenib dominate the market. However, fruquintinib, with its high selectivity, favorable safety profile, and clear clinical benefits, has established differentiated advantages in later-line treatment settings. On the policy side, its inclusion in the national reimbursement drug list helps improve patient accessibility and promote market expansion, although volume-based procurement and healthcare cost-control policies continue to exert downward pressure on pricing. From a competitive standpoint, the emergence of various anti-angiogenic therapies and combination regimens with immunotherapy from both domestic and international players is intensifying market competition. Therefore, the future market performance of fruquintinib will depend on its progress in expanding indications (such as gastric cancer and lung cancer), developing combination strategies, and accumulating real-world evidence, as well as its overall competitive balance in terms of efficacy, safety, and cost.
LP Information, Inc. (LPI) ' newest research report, the ?Fruquintinib Industry Forecast? looks at past sales and reviews total world Fruquintinib sales in 2025, providing a comprehensive analysis by region and market sector of projected Fruquintinib sales for 2026 through 2032. With Fruquintinib sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Fruquintinib industry.
This Insight Report provides a comprehensive analysis of the global Fruquintinib landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Fruquintinib portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Fruquintinib market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Fruquintinib and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Fruquintinib.
This report presents a comprehensive overview, market shares, and growth opportunities of Fruquintinib market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Fruquintinib market?
What factors are driving Fruquintinib market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Fruquintinib market opportunities vary by end market size?
How does Fruquintinib break out by Type, by Application?
In 2025, global production of fruquintinib reached approximately 810,000 units.Fruquintinib is an oral small-molecule highly selective vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitor, primarily used for the treatment of various solid tumors, with demonstrated efficacy particularly in metastatic colorectal cancer. It exerts its anti-tumor effects by selectively inhibiting VEGFR-1, VEGFR-2, and VEGFR-3 signaling pathways, thereby blocking angiogenesis and suppressing tumor growth and metastasis. Fruquintinib is characterized by high target selectivity, convenient oral administration, and good tolerability, making it clinically valuable in the treatment of advanced cancers, especially in later-line therapy settings.
Fruquintinib, as a highly selective VEGFR tyrosine kinase inhibitor, holds an important position in the oncology targeted therapy market, particularly demonstrating strong competitiveness in the later-line treatment of metastatic colorectal cancer. With the continuous rise in cancer incidence and the widespread adoption of precision medicine, the demand for anti-angiogenic therapies continues to grow, providing a stable market foundation for this drug. From a competitive landscape perspective, anti-angiogenic monoclonal antibodies such as Bevacizumab and small-molecule multi-target TKIs such as Regorafenib dominate the market. However, fruquintinib, with its high selectivity, favorable safety profile, and clear clinical benefits, has established differentiated advantages in later-line treatment settings. On the policy side, its inclusion in the national reimbursement drug list helps improve patient accessibility and promote market expansion, although volume-based procurement and healthcare cost-control policies continue to exert downward pressure on pricing. From a competitive standpoint, the emergence of various anti-angiogenic therapies and combination regimens with immunotherapy from both domestic and international players is intensifying market competition. Therefore, the future market performance of fruquintinib will depend on its progress in expanding indications (such as gastric cancer and lung cancer), developing combination strategies, and accumulating real-world evidence, as well as its overall competitive balance in terms of efficacy, safety, and cost.
LP Information, Inc. (LPI) ' newest research report, the ?Fruquintinib Industry Forecast? looks at past sales and reviews total world Fruquintinib sales in 2025, providing a comprehensive analysis by region and market sector of projected Fruquintinib sales for 2026 through 2032. With Fruquintinib sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Fruquintinib industry.
This Insight Report provides a comprehensive analysis of the global Fruquintinib landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Fruquintinib portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Fruquintinib market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Fruquintinib and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Fruquintinib.
This report presents a comprehensive overview, market shares, and growth opportunities of Fruquintinib market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- 1 mg capsule
- 5 mg capsule
- Hospital
- Retail
- Online
- Metastatic Colorectal Cancer (mCRC)
- Inhibit Tumor Angiogenesis
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Hutchison China MediTech Limited
- Takeda Pharmaceutical Company Limited
- Sichuan Qingmu Pharmaceutical
- Shanghai Boyi Chemical
What is the 10-year outlook for the global Fruquintinib market?
What factors are driving Fruquintinib market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Fruquintinib market opportunities vary by end market size?
How does Fruquintinib break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Fruquintinib Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Fruquintinib by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Fruquintinib by Country/Region, 2021, 2025 & 2032
2.2 Fruquintinib Segment by Type
2.2.1 1 mg capsule
2.2.2 5 mg capsule
2.2.3 Fruquintinib Sales by Type
2.2.3.1 Global Fruquintinib Sales Market Share by Type (2021-2026)
2.2.3.2 Global Fruquintinib Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Fruquintinib Sale Price by Type (2021-2026)
2.3 Fruquintinib Segment by Sales Channels
2.3.1 Hospital
2.3.2 Retail
2.3.3 Online
2.3.4 Fruquintinib Sales by Sales Channels
2.3.4.1 Global Fruquintinib Sales Market Share by Sales Channels (2021-2026)
2.3.4.2 Global Fruquintinib Revenue and Market Share by Sales Channels (2021-2026)
2.3.4.3 Global Fruquintinib Sale Price by Sales Channels (2021-2026)
2.4 Fruquintinib Segment by Application
2.4.1 Metastatic Colorectal Cancer (mCRC)
2.4.2 Inhibit Tumor Angiogenesis
2.4.3 Others
2.4.4 Fruquintinib Sales by Application
2.4.4.1 Global Fruquintinib Sale Market Share by Application (2021-2026)
2.4.4.2 Global Fruquintinib Revenue and Market Share by Application (2021-2026)
2.4.4.3 Global Fruquintinib Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Fruquintinib Breakdown Data by Company
3.1.1 Global Fruquintinib Annual Sales by Company (2021-2026)
3.1.2 Global Fruquintinib Sales Market Share by Company (2021-2026)
3.2 Global Fruquintinib Annual Revenue by Company (2021-2026)
3.2.1 Global Fruquintinib Revenue by Company (2021-2026)
3.2.2 Global Fruquintinib Revenue Market Share by Company (2021-2026)
3.3 Global Fruquintinib Sale Price by Company
3.4 Key Manufacturers Fruquintinib Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Fruquintinib Product Location Distribution
3.4.2 Players Fruquintinib Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR FRUQUINTINIB BY GEOGRAPHIC REGION
4.1 World Historic Fruquintinib Market Size by Geographic Region (2021-2026)
4.1.1 Global Fruquintinib Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Fruquintinib Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Fruquintinib Market Size by Country/Region (2021-2026)
4.2.1 Global Fruquintinib Annual Sales by Country/Region (2021-2026)
4.2.2 Global Fruquintinib Annual Revenue by Country/Region (2021-2026)
4.3 Americas Fruquintinib Sales Growth
4.4 APAC Fruquintinib Sales Growth
4.5 Europe Fruquintinib Sales Growth
4.6 Middle East & Africa Fruquintinib Sales Growth
5 AMERICAS
5.1 Americas Fruquintinib Sales by Country
5.1.1 Americas Fruquintinib Sales by Country (2021-2026)
5.1.2 Americas Fruquintinib Revenue by Country (2021-2026)
5.2 Americas Fruquintinib Sales by Type (2021-2026)
5.3 Americas Fruquintinib Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Fruquintinib Sales by Region
6.1.1 APAC Fruquintinib Sales by Region (2021-2026)
6.1.2 APAC Fruquintinib Revenue by Region (2021-2026)
6.2 APAC Fruquintinib Sales by Type (2021-2026)
6.3 APAC Fruquintinib Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Fruquintinib by Country
7.1.1 Europe Fruquintinib Sales by Country (2021-2026)
7.1.2 Europe Fruquintinib Revenue by Country (2021-2026)
7.2 Europe Fruquintinib Sales by Type (2021-2026)
7.3 Europe Fruquintinib Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Fruquintinib by Country
8.1.1 Middle East & Africa Fruquintinib Sales by Country (2021-2026)
8.1.2 Middle East & Africa Fruquintinib Revenue by Country (2021-2026)
8.2 Middle East & Africa Fruquintinib Sales by Type (2021-2026)
8.3 Middle East & Africa Fruquintinib Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Fruquintinib
10.3 Manufacturing Process Analysis of Fruquintinib
10.4 Industry Chain Structure of Fruquintinib
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Fruquintinib Distributors
11.3 Fruquintinib Customer
12 WORLD FORECAST REVIEW FOR FRUQUINTINIB BY GEOGRAPHIC REGION
12.1 Global Fruquintinib Market Size Forecast by Region
12.1.1 Global Fruquintinib Forecast by Region (2027-2032)
12.1.2 Global Fruquintinib Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Fruquintinib Forecast by Type (2027-2032)
12.7 Global Fruquintinib Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Hutchison China MediTech Limited
13.1.1 Hutchison China MediTech Limited Company Information
13.1.2 Hutchison China MediTech Limited Fruquintinib Product Portfolios and Specifications
13.1.3 Hutchison China MediTech Limited Fruquintinib Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Hutchison China MediTech Limited Main Business Overview
13.1.5 Hutchison China MediTech Limited Latest Developments
13.2 Takeda Pharmaceutical Company Limited
13.2.1 Takeda Pharmaceutical Company Limited Company Information
13.2.2 Takeda Pharmaceutical Company Limited Fruquintinib Product Portfolios and Specifications
13.2.3 Takeda Pharmaceutical Company Limited Fruquintinib Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Takeda Pharmaceutical Company Limited Main Business Overview
13.2.5 Takeda Pharmaceutical Company Limited Latest Developments
13.3 Sichuan Qingmu Pharmaceutical
13.3.1 Sichuan Qingmu Pharmaceutical Company Information
13.3.2 Sichuan Qingmu Pharmaceutical Fruquintinib Product Portfolios and Specifications
13.3.3 Sichuan Qingmu Pharmaceutical Fruquintinib Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Sichuan Qingmu Pharmaceutical Main Business Overview
13.3.5 Sichuan Qingmu Pharmaceutical Latest Developments
13.4 Shanghai Boyi Chemical
13.4.1 Shanghai Boyi Chemical Company Information
13.4.2 Shanghai Boyi Chemical Fruquintinib Product Portfolios and Specifications
13.4.3 Shanghai Boyi Chemical Fruquintinib Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Shanghai Boyi Chemical Main Business Overview
13.4.5 Shanghai Boyi Chemical Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Fruquintinib Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Fruquintinib by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Fruquintinib by Country/Region, 2021, 2025 & 2032
2.2 Fruquintinib Segment by Type
2.2.1 1 mg capsule
2.2.2 5 mg capsule
2.2.3 Fruquintinib Sales by Type
2.2.3.1 Global Fruquintinib Sales Market Share by Type (2021-2026)
2.2.3.2 Global Fruquintinib Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Fruquintinib Sale Price by Type (2021-2026)
2.3 Fruquintinib Segment by Sales Channels
2.3.1 Hospital
2.3.2 Retail
2.3.3 Online
2.3.4 Fruquintinib Sales by Sales Channels
2.3.4.1 Global Fruquintinib Sales Market Share by Sales Channels (2021-2026)
2.3.4.2 Global Fruquintinib Revenue and Market Share by Sales Channels (2021-2026)
2.3.4.3 Global Fruquintinib Sale Price by Sales Channels (2021-2026)
2.4 Fruquintinib Segment by Application
2.4.1 Metastatic Colorectal Cancer (mCRC)
2.4.2 Inhibit Tumor Angiogenesis
2.4.3 Others
2.4.4 Fruquintinib Sales by Application
2.4.4.1 Global Fruquintinib Sale Market Share by Application (2021-2026)
2.4.4.2 Global Fruquintinib Revenue and Market Share by Application (2021-2026)
2.4.4.3 Global Fruquintinib Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Fruquintinib Breakdown Data by Company
3.1.1 Global Fruquintinib Annual Sales by Company (2021-2026)
3.1.2 Global Fruquintinib Sales Market Share by Company (2021-2026)
3.2 Global Fruquintinib Annual Revenue by Company (2021-2026)
3.2.1 Global Fruquintinib Revenue by Company (2021-2026)
3.2.2 Global Fruquintinib Revenue Market Share by Company (2021-2026)
3.3 Global Fruquintinib Sale Price by Company
3.4 Key Manufacturers Fruquintinib Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Fruquintinib Product Location Distribution
3.4.2 Players Fruquintinib Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR FRUQUINTINIB BY GEOGRAPHIC REGION
4.1 World Historic Fruquintinib Market Size by Geographic Region (2021-2026)
4.1.1 Global Fruquintinib Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Fruquintinib Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Fruquintinib Market Size by Country/Region (2021-2026)
4.2.1 Global Fruquintinib Annual Sales by Country/Region (2021-2026)
4.2.2 Global Fruquintinib Annual Revenue by Country/Region (2021-2026)
4.3 Americas Fruquintinib Sales Growth
4.4 APAC Fruquintinib Sales Growth
4.5 Europe Fruquintinib Sales Growth
4.6 Middle East & Africa Fruquintinib Sales Growth
5 AMERICAS
5.1 Americas Fruquintinib Sales by Country
5.1.1 Americas Fruquintinib Sales by Country (2021-2026)
5.1.2 Americas Fruquintinib Revenue by Country (2021-2026)
5.2 Americas Fruquintinib Sales by Type (2021-2026)
5.3 Americas Fruquintinib Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Fruquintinib Sales by Region
6.1.1 APAC Fruquintinib Sales by Region (2021-2026)
6.1.2 APAC Fruquintinib Revenue by Region (2021-2026)
6.2 APAC Fruquintinib Sales by Type (2021-2026)
6.3 APAC Fruquintinib Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Fruquintinib by Country
7.1.1 Europe Fruquintinib Sales by Country (2021-2026)
7.1.2 Europe Fruquintinib Revenue by Country (2021-2026)
7.2 Europe Fruquintinib Sales by Type (2021-2026)
7.3 Europe Fruquintinib Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Fruquintinib by Country
8.1.1 Middle East & Africa Fruquintinib Sales by Country (2021-2026)
8.1.2 Middle East & Africa Fruquintinib Revenue by Country (2021-2026)
8.2 Middle East & Africa Fruquintinib Sales by Type (2021-2026)
8.3 Middle East & Africa Fruquintinib Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Fruquintinib
10.3 Manufacturing Process Analysis of Fruquintinib
10.4 Industry Chain Structure of Fruquintinib
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Fruquintinib Distributors
11.3 Fruquintinib Customer
12 WORLD FORECAST REVIEW FOR FRUQUINTINIB BY GEOGRAPHIC REGION
12.1 Global Fruquintinib Market Size Forecast by Region
12.1.1 Global Fruquintinib Forecast by Region (2027-2032)
12.1.2 Global Fruquintinib Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Fruquintinib Forecast by Type (2027-2032)
12.7 Global Fruquintinib Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Hutchison China MediTech Limited
13.1.1 Hutchison China MediTech Limited Company Information
13.1.2 Hutchison China MediTech Limited Fruquintinib Product Portfolios and Specifications
13.1.3 Hutchison China MediTech Limited Fruquintinib Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Hutchison China MediTech Limited Main Business Overview
13.1.5 Hutchison China MediTech Limited Latest Developments
13.2 Takeda Pharmaceutical Company Limited
13.2.1 Takeda Pharmaceutical Company Limited Company Information
13.2.2 Takeda Pharmaceutical Company Limited Fruquintinib Product Portfolios and Specifications
13.2.3 Takeda Pharmaceutical Company Limited Fruquintinib Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Takeda Pharmaceutical Company Limited Main Business Overview
13.2.5 Takeda Pharmaceutical Company Limited Latest Developments
13.3 Sichuan Qingmu Pharmaceutical
13.3.1 Sichuan Qingmu Pharmaceutical Company Information
13.3.2 Sichuan Qingmu Pharmaceutical Fruquintinib Product Portfolios and Specifications
13.3.3 Sichuan Qingmu Pharmaceutical Fruquintinib Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Sichuan Qingmu Pharmaceutical Main Business Overview
13.3.5 Sichuan Qingmu Pharmaceutical Latest Developments
13.4 Shanghai Boyi Chemical
13.4.1 Shanghai Boyi Chemical Company Information
13.4.2 Shanghai Boyi Chemical Fruquintinib Product Portfolios and Specifications
13.4.3 Shanghai Boyi Chemical Fruquintinib Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Shanghai Boyi Chemical Main Business Overview
13.4.5 Shanghai Boyi Chemical Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Fruquintinib Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Fruquintinib Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of 1 mg capsule
Table 4. Major Players of 5 mg capsule
Table 5. Global Fruquintinib Sales by Type (2021-2026) & (Units)
Table 6. Global Fruquintinib Sales Market Share by Type (2021-2026)
Table 7. Global Fruquintinib Revenue by Type (2021-2026) & ($ million)
Table 8. Global Fruquintinib Revenue Market Share by Type (2021-2026)
Table 9. Global Fruquintinib Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Major Players of Hospital
Table 11. Major Players of Retail
Table 12. Major Players of Online
Table 13. Global Fruquintinib Sales by Sales Channels (2021-2026) & (Units)
Table 14. Global Fruquintinib Sales Market Share by Sales Channels (2021-2026)
Table 15. Global Fruquintinib Revenue by Sales Channels (2021-2026) & ($ million)
Table 16. Global Fruquintinib Revenue Market Share by Sales Channels (2021-2026)
Table 17. Global Fruquintinib Sale Price by Sales Channels (2021-2026) & (US$/Unit)
Table 18. Major Players ofTablet
Table 19. Major Players of Capsule
Table 20. Global Fruquintinib Sale by Application (2021-2026) & (Units)
Table 21. Global Fruquintinib Sale Market Share by Application (2021-2026)
Table 22. Global Fruquintinib Revenue by Application (2021-2026) & ($ million)
Table 23. Global Fruquintinib Revenue Market Share by Application (2021-2026)
Table 24. Global Fruquintinib Sale Price by Application (2021-2026) & (US$/Unit)
Table 25. Global Fruquintinib Sales by Company (2021-2026) & (Units)
Table 26. Global Fruquintinib Sales Market Share by Company (2021-2026)
Table 27. Global Fruquintinib Revenue by Company (2021-2026) & ($ millions)
Table 28. Global Fruquintinib Revenue Market Share by Company (2021-2026)
Table 29. Global Fruquintinib Sale Price by Company (2021-2026) & (US$/Unit)
Table 30. Key Manufacturers Fruquintinib Producing Area Distribution and Sales Area
Table 31. Players Fruquintinib Products Offered
Table 32. Fruquintinib Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 33. New Products and Potential Entrants
Table 34. Market M&A Activity & Strategy
Table 35. Global Fruquintinib Sales by Geographic Region (2021-2026) & (Units)
Table 36. Global Fruquintinib Sales Market Share Geographic Region (2021-2026)
Table 37. Global Fruquintinib Revenue by Geographic Region (2021-2026) & ($ millions)
Table 38. Global Fruquintinib Revenue Market Share by Geographic Region (2021-2026)
Table 39. Global Fruquintinib Sales by Country/Region (2021-2026) & (Units)
Table 40. Global Fruquintinib Sales Market Share by Country/Region (2021-2026)
Table 41. Global Fruquintinib Revenue by Country/Region (2021-2026) & ($ millions)
Table 42. Global Fruquintinib Revenue Market Share by Country/Region (2021-2026)
Table 43. Americas Fruquintinib Sales by Country (2021-2026) & (Units)
Table 44. Americas Fruquintinib Sales Market Share by Country (2021-2026)
Table 45. Americas Fruquintinib Revenue by Country (2021-2026) & ($ millions)
Table 46. Americas Fruquintinib Sales by Type (2021-2026) & (Units)
Table 47. Americas Fruquintinib Sales by Application (2021-2026) & (Units)
Table 48. APAC Fruquintinib Sales by Region (2021-2026) & (Units)
Table 49. APAC Fruquintinib Sales Market Share by Region (2021-2026)
Table 50. APAC Fruquintinib Revenue by Region (2021-2026) & ($ millions)
Table 51. APAC Fruquintinib Sales by Type (2021-2026) & (Units)
Table 52. APAC Fruquintinib Sales by Application (2021-2026) & (Units)
Table 53. Europe Fruquintinib Sales by Country (2021-2026) & (Units)
Table 54. Europe Fruquintinib Revenue by Country (2021-2026) & ($ millions)
Table 55. Europe Fruquintinib Sales by Type (2021-2026) & (Units)
Table 56. Europe Fruquintinib Sales by Application (2021-2026) & (Units)
Table 57. Middle East & Africa Fruquintinib Sales by Country (2021-2026) & (Units)
Table 58. Middle East & Africa Fruquintinib Revenue Market Share by Country (2021-2026)
Table 59. Middle East & Africa Fruquintinib Sales by Type (2021-2026) & (Units)
Table 60. Middle East & Africa Fruquintinib Sales by Application (2021-2026) & (Units)
Table 61. Key Market Drivers & Growth Opportunities of Fruquintinib
Table 62. Key Market Challenges & Risks of Fruquintinib
Table 63. Key Industry Trends of Fruquintinib
Table 64. Fruquintinib Raw Material
Table 65. Key Suppliers of Raw Materials
Table 66. Fruquintinib Distributors List
Table 67. Fruquintinib Customer List
Table 68. Global Fruquintinib Sales Forecast by Region (2027-2032) & (Units)
Table 69. Global Fruquintinib Revenue Forecast by Region (2027-2032) & ($ millions)
Table 70. Americas Fruquintinib Sales Forecast by Country (2027-2032) & (Units)
Table 71. Americas Fruquintinib Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 72. APAC Fruquintinib Sales Forecast by Region (2027-2032) & (Units)
Table 73. APAC Fruquintinib Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 74. Europe Fruquintinib Sales Forecast by Country (2027-2032) & (Units)
Table 75. Europe Fruquintinib Revenue Forecast by Country (2027-2032) & ($ millions)
Table 76. Middle East & Africa Fruquintinib Sales Forecast by Country (2027-2032) & (Units)
Table 77. Middle East & Africa Fruquintinib Revenue Forecast by Country (2027-2032) & ($ millions)
Table 78. Global Fruquintinib Sales Forecast by Type (2027-2032) & (Units)
Table 79. Global Fruquintinib Revenue Forecast by Type (2027-2032) & ($ millions)
Table 80. Global Fruquintinib Sales Forecast by Application (2027-2032) & (Units)
Table 81. Global Fruquintinib Revenue Forecast by Application (2027-2032) & ($ millions)
Table 82. Hutchison China MediTech Limited Basic Information, Fruquintinib Manufacturing Base, Sales Area and Its Competitors
Table 83. Hutchison China MediTech Limited Fruquintinib Product Portfolios and Specifications
Table 84. Hutchison China MediTech Limited Fruquintinib Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. Hutchison China MediTech Limited Main Business
Table 86. Hutchison China MediTech Limited Latest Developments
Table 87. Takeda Pharmaceutical Company Limited Basic Information, Fruquintinib Manufacturing Base, Sales Area and Its Competitors
Table 88. Takeda Pharmaceutical Company Limited Fruquintinib Product Portfolios and Specifications
Table 89. Takeda Pharmaceutical Company Limited Fruquintinib Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. Takeda Pharmaceutical Company Limited Main Business
Table 91. Takeda Pharmaceutical Company Limited Latest Developments
Table 92. Sichuan Qingmu Pharmaceutical Basic Information, Fruquintinib Manufacturing Base, Sales Area and Its Competitors
Table 93. Sichuan Qingmu Pharmaceutical Fruquintinib Product Portfolios and Specifications
Table 94. Sichuan Qingmu Pharmaceutical Fruquintinib Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. Sichuan Qingmu Pharmaceutical Main Business
Table 96. Sichuan Qingmu Pharmaceutical Latest Developments
Table 97. Shanghai Boyi Chemical Basic Information, Fruquintinib Manufacturing Base, Sales Area and Its Competitors
Table 98. Shanghai Boyi Chemical Fruquintinib Product Portfolios and Specifications
Table 99. Shanghai Boyi Chemical Fruquintinib Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. Shanghai Boyi Chemical Main Business
Table 101. Shanghai Boyi Chemical Latest Developments
Table 1. Fruquintinib Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Fruquintinib Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of 1 mg capsule
Table 4. Major Players of 5 mg capsule
Table 5. Global Fruquintinib Sales by Type (2021-2026) & (Units)
Table 6. Global Fruquintinib Sales Market Share by Type (2021-2026)
Table 7. Global Fruquintinib Revenue by Type (2021-2026) & ($ million)
Table 8. Global Fruquintinib Revenue Market Share by Type (2021-2026)
Table 9. Global Fruquintinib Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Major Players of Hospital
Table 11. Major Players of Retail
Table 12. Major Players of Online
Table 13. Global Fruquintinib Sales by Sales Channels (2021-2026) & (Units)
Table 14. Global Fruquintinib Sales Market Share by Sales Channels (2021-2026)
Table 15. Global Fruquintinib Revenue by Sales Channels (2021-2026) & ($ million)
Table 16. Global Fruquintinib Revenue Market Share by Sales Channels (2021-2026)
Table 17. Global Fruquintinib Sale Price by Sales Channels (2021-2026) & (US$/Unit)
Table 18. Major Players ofTablet
Table 19. Major Players of Capsule
Table 20. Global Fruquintinib Sale by Application (2021-2026) & (Units)
Table 21. Global Fruquintinib Sale Market Share by Application (2021-2026)
Table 22. Global Fruquintinib Revenue by Application (2021-2026) & ($ million)
Table 23. Global Fruquintinib Revenue Market Share by Application (2021-2026)
Table 24. Global Fruquintinib Sale Price by Application (2021-2026) & (US$/Unit)
Table 25. Global Fruquintinib Sales by Company (2021-2026) & (Units)
Table 26. Global Fruquintinib Sales Market Share by Company (2021-2026)
Table 27. Global Fruquintinib Revenue by Company (2021-2026) & ($ millions)
Table 28. Global Fruquintinib Revenue Market Share by Company (2021-2026)
Table 29. Global Fruquintinib Sale Price by Company (2021-2026) & (US$/Unit)
Table 30. Key Manufacturers Fruquintinib Producing Area Distribution and Sales Area
Table 31. Players Fruquintinib Products Offered
Table 32. Fruquintinib Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 33. New Products and Potential Entrants
Table 34. Market M&A Activity & Strategy
Table 35. Global Fruquintinib Sales by Geographic Region (2021-2026) & (Units)
Table 36. Global Fruquintinib Sales Market Share Geographic Region (2021-2026)
Table 37. Global Fruquintinib Revenue by Geographic Region (2021-2026) & ($ millions)
Table 38. Global Fruquintinib Revenue Market Share by Geographic Region (2021-2026)
Table 39. Global Fruquintinib Sales by Country/Region (2021-2026) & (Units)
Table 40. Global Fruquintinib Sales Market Share by Country/Region (2021-2026)
Table 41. Global Fruquintinib Revenue by Country/Region (2021-2026) & ($ millions)
Table 42. Global Fruquintinib Revenue Market Share by Country/Region (2021-2026)
Table 43. Americas Fruquintinib Sales by Country (2021-2026) & (Units)
Table 44. Americas Fruquintinib Sales Market Share by Country (2021-2026)
Table 45. Americas Fruquintinib Revenue by Country (2021-2026) & ($ millions)
Table 46. Americas Fruquintinib Sales by Type (2021-2026) & (Units)
Table 47. Americas Fruquintinib Sales by Application (2021-2026) & (Units)
Table 48. APAC Fruquintinib Sales by Region (2021-2026) & (Units)
Table 49. APAC Fruquintinib Sales Market Share by Region (2021-2026)
Table 50. APAC Fruquintinib Revenue by Region (2021-2026) & ($ millions)
Table 51. APAC Fruquintinib Sales by Type (2021-2026) & (Units)
Table 52. APAC Fruquintinib Sales by Application (2021-2026) & (Units)
Table 53. Europe Fruquintinib Sales by Country (2021-2026) & (Units)
Table 54. Europe Fruquintinib Revenue by Country (2021-2026) & ($ millions)
Table 55. Europe Fruquintinib Sales by Type (2021-2026) & (Units)
Table 56. Europe Fruquintinib Sales by Application (2021-2026) & (Units)
Table 57. Middle East & Africa Fruquintinib Sales by Country (2021-2026) & (Units)
Table 58. Middle East & Africa Fruquintinib Revenue Market Share by Country (2021-2026)
Table 59. Middle East & Africa Fruquintinib Sales by Type (2021-2026) & (Units)
Table 60. Middle East & Africa Fruquintinib Sales by Application (2021-2026) & (Units)
Table 61. Key Market Drivers & Growth Opportunities of Fruquintinib
Table 62. Key Market Challenges & Risks of Fruquintinib
Table 63. Key Industry Trends of Fruquintinib
Table 64. Fruquintinib Raw Material
Table 65. Key Suppliers of Raw Materials
Table 66. Fruquintinib Distributors List
Table 67. Fruquintinib Customer List
Table 68. Global Fruquintinib Sales Forecast by Region (2027-2032) & (Units)
Table 69. Global Fruquintinib Revenue Forecast by Region (2027-2032) & ($ millions)
Table 70. Americas Fruquintinib Sales Forecast by Country (2027-2032) & (Units)
Table 71. Americas Fruquintinib Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 72. APAC Fruquintinib Sales Forecast by Region (2027-2032) & (Units)
Table 73. APAC Fruquintinib Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 74. Europe Fruquintinib Sales Forecast by Country (2027-2032) & (Units)
Table 75. Europe Fruquintinib Revenue Forecast by Country (2027-2032) & ($ millions)
Table 76. Middle East & Africa Fruquintinib Sales Forecast by Country (2027-2032) & (Units)
Table 77. Middle East & Africa Fruquintinib Revenue Forecast by Country (2027-2032) & ($ millions)
Table 78. Global Fruquintinib Sales Forecast by Type (2027-2032) & (Units)
Table 79. Global Fruquintinib Revenue Forecast by Type (2027-2032) & ($ millions)
Table 80. Global Fruquintinib Sales Forecast by Application (2027-2032) & (Units)
Table 81. Global Fruquintinib Revenue Forecast by Application (2027-2032) & ($ millions)
Table 82. Hutchison China MediTech Limited Basic Information, Fruquintinib Manufacturing Base, Sales Area and Its Competitors
Table 83. Hutchison China MediTech Limited Fruquintinib Product Portfolios and Specifications
Table 84. Hutchison China MediTech Limited Fruquintinib Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. Hutchison China MediTech Limited Main Business
Table 86. Hutchison China MediTech Limited Latest Developments
Table 87. Takeda Pharmaceutical Company Limited Basic Information, Fruquintinib Manufacturing Base, Sales Area and Its Competitors
Table 88. Takeda Pharmaceutical Company Limited Fruquintinib Product Portfolios and Specifications
Table 89. Takeda Pharmaceutical Company Limited Fruquintinib Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. Takeda Pharmaceutical Company Limited Main Business
Table 91. Takeda Pharmaceutical Company Limited Latest Developments
Table 92. Sichuan Qingmu Pharmaceutical Basic Information, Fruquintinib Manufacturing Base, Sales Area and Its Competitors
Table 93. Sichuan Qingmu Pharmaceutical Fruquintinib Product Portfolios and Specifications
Table 94. Sichuan Qingmu Pharmaceutical Fruquintinib Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. Sichuan Qingmu Pharmaceutical Main Business
Table 96. Sichuan Qingmu Pharmaceutical Latest Developments
Table 97. Shanghai Boyi Chemical Basic Information, Fruquintinib Manufacturing Base, Sales Area and Its Competitors
Table 98. Shanghai Boyi Chemical Fruquintinib Product Portfolios and Specifications
Table 99. Shanghai Boyi Chemical Fruquintinib Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. Shanghai Boyi Chemical Main Business
Table 101. Shanghai Boyi Chemical Latest Developments
LIST OF FIGURES
Figure 1. Picture of Fruquintinib
Figure 2. Fruquintinib Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Fruquintinib Sales Growth Rate 2021-2032 (Units)
Figure 7. Global Fruquintinib Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Fruquintinib Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Fruquintinib Sales Market Share by Country/Region (2025)
Figure 10. Fruquintinib Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of 1 mg capsule
Figure 12. Product Picture of 5 mg capsule
Figure 13. Global Fruquintinib Sales Market Share by Type in 2026
Figure 14. Global Fruquintinib Revenue Market Share by Type (2021-2026)
Figure 15. Product Picture of Hospital
Figure 16. Product Picture of Retail
Figure 17. Product Picture of Online
Figure 18. Global Fruquintinib Sales Market Share by Sales Channels in 2026
Figure 19. Global Fruquintinib Revenue Market Share by Sales Channels (2021-2026)
Figure 20. Product Picture ofTablet
Figure 21. Product Picture of Capsule
Figure 22. Fruquintinib Consumed in Metastatic Colorectal Cancer (mCRC)
Figure 23. Global Fruquintinib Market: Metastatic Colorectal Cancer (mCRC) (2021-2026) & (Units)
Figure 24. Fruquintinib Consumed in Inhibit Tumor Angiogenesis
Figure 25. Global Fruquintinib Market: Inhibit Tumor Angiogenesis (2021-2026) & (Units)
Figure 26. Fruquintinib Consumed in Others
Figure 27. Global Fruquintinib Market: Others (2021-2026) & (Units)
Figure 28. Global Fruquintinib Sale Market Share by Application (2025)
Figure 29. Global Fruquintinib Revenue Market Share by Application in 2025
Figure 30. Fruquintinib Sales by Company in 2025 (Units)
Figure 31. Global Fruquintinib Sales Market Share by Company in 2025
Figure 32. Fruquintinib Revenue by Company in 2025 ($ millions)
Figure 33. Global Fruquintinib Revenue Market Share by Company in 2025
Figure 34. Global Fruquintinib Sales Market Share by Geographic Region (2021-2026)
Figure 35. Global Fruquintinib Revenue Market Share by Geographic Region in 2025
Figure 36. Americas Fruquintinib Sales 2021-2026 (Units)
Figure 37. Americas Fruquintinib Revenue 2021-2026 ($ millions)
Figure 38. APAC Fruquintinib Sales 2021-2026 (Units)
Figure 39. APAC Fruquintinib Revenue 2021-2026 ($ millions)
Figure 40. Europe Fruquintinib Sales 2021-2026 (Units)
Figure 41. Europe Fruquintinib Revenue 2021-2026 ($ millions)
Figure 42. Middle East & Africa Fruquintinib Sales 2021-2026 (Units)
Figure 43. Middle East & Africa Fruquintinib Revenue 2021-2026 ($ millions)
Figure 44. Americas Fruquintinib Sales Market Share by Country in 2025
Figure 45. Americas Fruquintinib Revenue Market Share by Country (2021-2026)
Figure 46. Americas Fruquintinib Sales Market Share by Type (2021-2026)
Figure 47. Americas Fruquintinib Sales Market Share by Application (2021-2026)
Figure 48. United States Fruquintinib Revenue Growth 2021-2026 ($ millions)
Figure 49. Canada Fruquintinib Revenue Growth 2021-2026 ($ millions)
Figure 50. Mexico Fruquintinib Revenue Growth 2021-2026 ($ millions)
Figure 51. Brazil Fruquintinib Revenue Growth 2021-2026 ($ millions)
Figure 52. APAC Fruquintinib Sales Market Share by Region in 2025
Figure 53. APAC Fruquintinib Revenue Market Share by Region (2021-2026)
Figure 54. APAC Fruquintinib Sales Market Share by Type (2021-2026)
Figure 55. APAC Fruquintinib Sales Market Share by Application (2021-2026)
Figure 56. China Fruquintinib Revenue Growth 2021-2026 ($ millions)
Figure 57. Japan Fruquintinib Revenue Growth 2021-2026 ($ millions)
Figure 58. South Korea Fruquintinib Revenue Growth 2021-2026 ($ millions)
Figure 59. Southeast Asia Fruquintinib Revenue Growth 2021-2026 ($ millions)
Figure 60. India Fruquintinib Revenue Growth 2021-2026 ($ millions)
Figure 61. Australia Fruquintinib Revenue Growth 2021-2026 ($ millions)
Figure 62. China Taiwan Fruquintinib Revenue Growth 2021-2026 ($ millions)
Figure 63. Europe Fruquintinib Sales Market Share by Country in 2025
Figure 64. Europe Fruquintinib Revenue Market Share by Country (2021-2026)
Figure 65. Europe Fruquintinib Sales Market Share by Type (2021-2026)
Figure 66. Europe Fruquintinib Sales Market Share by Application (2021-2026)
Figure 67. Germany Fruquintinib Revenue Growth 2021-2026 ($ millions)
Figure 68. France Fruquintinib Revenue Growth 2021-2026 ($ millions)
Figure 69. UK Fruquintinib Revenue Growth 2021-2026 ($ millions)
Figure 70. Italy Fruquintinib Revenue Growth 2021-2026 ($ millions)
Figure 71. Russia Fruquintinib Revenue Growth 2021-2026 ($ millions)
Figure 72. Middle East & Africa Fruquintinib Sales Market Share by Country (2021-2026)
Figure 73. Middle East & Africa Fruquintinib Sales Market Share by Type (2021-2026)
Figure 74. Middle East & Africa Fruquintinib Sales Market Share by Application (2021-2026)
Figure 75. Egypt Fruquintinib Revenue Growth 2021-2026 ($ millions)
Figure 76. South Africa Fruquintinib Revenue Growth 2021-2026 ($ millions)
Figure 77. Israel Fruquintinib Revenue Growth 2021-2026 ($ millions)
Figure 78. Turkey Fruquintinib Revenue Growth 2021-2026 ($ millions)
Figure 79. GCC Countries Fruquintinib Revenue Growth 2021-2026 ($ millions)
Figure 80. Manufacturing Cost Structure Analysis of Fruquintinib in 2026
Figure 81. Manufacturing Process Analysis of Fruquintinib
Figure 82. Industry Chain Structure of Fruquintinib
Figure 83. Channels of Distribution
Figure 84. Global Fruquintinib Sales Market Forecast by Region (2027-2032)
Figure 85. Global Fruquintinib Revenue Market Share Forecast by Region (2027-2032)
Figure 86. Global Fruquintinib Sales Market Share Forecast by Type (2027-2032)
Figure 87. Global Fruquintinib Revenue Market Share Forecast by Type (2027-2032)
Figure 88. Global Fruquintinib Sales Market Share Forecast by Application (2027-2032)
Figure 89. Global Fruquintinib Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Fruquintinib
Figure 2. Fruquintinib Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Fruquintinib Sales Growth Rate 2021-2032 (Units)
Figure 7. Global Fruquintinib Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Fruquintinib Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Fruquintinib Sales Market Share by Country/Region (2025)
Figure 10. Fruquintinib Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of 1 mg capsule
Figure 12. Product Picture of 5 mg capsule
Figure 13. Global Fruquintinib Sales Market Share by Type in 2026
Figure 14. Global Fruquintinib Revenue Market Share by Type (2021-2026)
Figure 15. Product Picture of Hospital
Figure 16. Product Picture of Retail
Figure 17. Product Picture of Online
Figure 18. Global Fruquintinib Sales Market Share by Sales Channels in 2026
Figure 19. Global Fruquintinib Revenue Market Share by Sales Channels (2021-2026)
Figure 20. Product Picture ofTablet
Figure 21. Product Picture of Capsule
Figure 22. Fruquintinib Consumed in Metastatic Colorectal Cancer (mCRC)
Figure 23. Global Fruquintinib Market: Metastatic Colorectal Cancer (mCRC) (2021-2026) & (Units)
Figure 24. Fruquintinib Consumed in Inhibit Tumor Angiogenesis
Figure 25. Global Fruquintinib Market: Inhibit Tumor Angiogenesis (2021-2026) & (Units)
Figure 26. Fruquintinib Consumed in Others
Figure 27. Global Fruquintinib Market: Others (2021-2026) & (Units)
Figure 28. Global Fruquintinib Sale Market Share by Application (2025)
Figure 29. Global Fruquintinib Revenue Market Share by Application in 2025
Figure 30. Fruquintinib Sales by Company in 2025 (Units)
Figure 31. Global Fruquintinib Sales Market Share by Company in 2025
Figure 32. Fruquintinib Revenue by Company in 2025 ($ millions)
Figure 33. Global Fruquintinib Revenue Market Share by Company in 2025
Figure 34. Global Fruquintinib Sales Market Share by Geographic Region (2021-2026)
Figure 35. Global Fruquintinib Revenue Market Share by Geographic Region in 2025
Figure 36. Americas Fruquintinib Sales 2021-2026 (Units)
Figure 37. Americas Fruquintinib Revenue 2021-2026 ($ millions)
Figure 38. APAC Fruquintinib Sales 2021-2026 (Units)
Figure 39. APAC Fruquintinib Revenue 2021-2026 ($ millions)
Figure 40. Europe Fruquintinib Sales 2021-2026 (Units)
Figure 41. Europe Fruquintinib Revenue 2021-2026 ($ millions)
Figure 42. Middle East & Africa Fruquintinib Sales 2021-2026 (Units)
Figure 43. Middle East & Africa Fruquintinib Revenue 2021-2026 ($ millions)
Figure 44. Americas Fruquintinib Sales Market Share by Country in 2025
Figure 45. Americas Fruquintinib Revenue Market Share by Country (2021-2026)
Figure 46. Americas Fruquintinib Sales Market Share by Type (2021-2026)
Figure 47. Americas Fruquintinib Sales Market Share by Application (2021-2026)
Figure 48. United States Fruquintinib Revenue Growth 2021-2026 ($ millions)
Figure 49. Canada Fruquintinib Revenue Growth 2021-2026 ($ millions)
Figure 50. Mexico Fruquintinib Revenue Growth 2021-2026 ($ millions)
Figure 51. Brazil Fruquintinib Revenue Growth 2021-2026 ($ millions)
Figure 52. APAC Fruquintinib Sales Market Share by Region in 2025
Figure 53. APAC Fruquintinib Revenue Market Share by Region (2021-2026)
Figure 54. APAC Fruquintinib Sales Market Share by Type (2021-2026)
Figure 55. APAC Fruquintinib Sales Market Share by Application (2021-2026)
Figure 56. China Fruquintinib Revenue Growth 2021-2026 ($ millions)
Figure 57. Japan Fruquintinib Revenue Growth 2021-2026 ($ millions)
Figure 58. South Korea Fruquintinib Revenue Growth 2021-2026 ($ millions)
Figure 59. Southeast Asia Fruquintinib Revenue Growth 2021-2026 ($ millions)
Figure 60. India Fruquintinib Revenue Growth 2021-2026 ($ millions)
Figure 61. Australia Fruquintinib Revenue Growth 2021-2026 ($ millions)
Figure 62. China Taiwan Fruquintinib Revenue Growth 2021-2026 ($ millions)
Figure 63. Europe Fruquintinib Sales Market Share by Country in 2025
Figure 64. Europe Fruquintinib Revenue Market Share by Country (2021-2026)
Figure 65. Europe Fruquintinib Sales Market Share by Type (2021-2026)
Figure 66. Europe Fruquintinib Sales Market Share by Application (2021-2026)
Figure 67. Germany Fruquintinib Revenue Growth 2021-2026 ($ millions)
Figure 68. France Fruquintinib Revenue Growth 2021-2026 ($ millions)
Figure 69. UK Fruquintinib Revenue Growth 2021-2026 ($ millions)
Figure 70. Italy Fruquintinib Revenue Growth 2021-2026 ($ millions)
Figure 71. Russia Fruquintinib Revenue Growth 2021-2026 ($ millions)
Figure 72. Middle East & Africa Fruquintinib Sales Market Share by Country (2021-2026)
Figure 73. Middle East & Africa Fruquintinib Sales Market Share by Type (2021-2026)
Figure 74. Middle East & Africa Fruquintinib Sales Market Share by Application (2021-2026)
Figure 75. Egypt Fruquintinib Revenue Growth 2021-2026 ($ millions)
Figure 76. South Africa Fruquintinib Revenue Growth 2021-2026 ($ millions)
Figure 77. Israel Fruquintinib Revenue Growth 2021-2026 ($ millions)
Figure 78. Turkey Fruquintinib Revenue Growth 2021-2026 ($ millions)
Figure 79. GCC Countries Fruquintinib Revenue Growth 2021-2026 ($ millions)
Figure 80. Manufacturing Cost Structure Analysis of Fruquintinib in 2026
Figure 81. Manufacturing Process Analysis of Fruquintinib
Figure 82. Industry Chain Structure of Fruquintinib
Figure 83. Channels of Distribution
Figure 84. Global Fruquintinib Sales Market Forecast by Region (2027-2032)
Figure 85. Global Fruquintinib Revenue Market Share Forecast by Region (2027-2032)
Figure 86. Global Fruquintinib Sales Market Share Forecast by Type (2027-2032)
Figure 87. Global Fruquintinib Revenue Market Share Forecast by Type (2027-2032)
Figure 88. Global Fruquintinib Sales Market Share Forecast by Application (2027-2032)
Figure 89. Global Fruquintinib Revenue Market Share Forecast by Application (2027-2032)
